Found: 20
Select item for more details and to access through your institution.
Predictive metabolic networks reveal sex‐ and APOE genotype‐specific metabolic signatures and drivers for precision medicine in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 2, p. 518, doi. 10.1002/alz.12675
- By:
- Publication type:
- Article
Transcriptomics, metabolomics, lipidomics, metabolic flux and mGWAS analyses of sphingolipid pathway highlights novel drugs for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056152
- By:
- Publication type:
- Article
Investigating the importance of acylcarnitines in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.056647
- By:
- Publication type:
- Article
Serum metabolome informs neuroimaging biomarkers for Alzheimer's disease: Genome‐metabolome‐phenome: Towards an integrated molecular atlas for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045596
- By:
- Publication type:
- Article
Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 9, p. 1234, doi. 10.1002/alz.12110
- By:
- Publication type:
- Article
P1‐386: ASSOCIATION OF SERUM‐BASED PLASMALOGENS WITH NEUROIMAGING AND GENETIC VARIATION IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P403, doi. 10.1016/j.jalz.2019.06.941
- By:
- Publication type:
- Article
Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 2, p. 232, doi. 10.1016/j.jalz.2018.08.012
- By:
- Publication type:
- Article
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 1, p. 76, doi. 10.1016/j.jalz.2018.07.217
- By:
- Publication type:
- Article
F3‐02‐01: ALTERED BILE ACID METABOLITES IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE: RELATION TO NEUROIMAGING AND CSF BIOMARKERS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P997, doi. 10.1016/j.jalz.2018.06.2744
- By:
- Publication type:
- Article
F3‐02‐04: SERUM INDICES OF ETHANOLAMINE PLASMALOGENS AND PHOSPHATIDE METABOLISM IN THE COMBINED ADNI‐1/GO/2 COHORT: DOES THE LIVER CONTRIBUTE TO AD RISK BY FAILING TO SUPPLY KEY LIPIDS TO THE BRAIN?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P998, doi. 10.1016/j.jalz.2018.06.2747
- By:
- Publication type:
- Article
Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts.
- Published in:
- Scientific Data, 2019, v. 6, n. 1, p. N.PAG, doi. 10.1038/s41597-019-0181-8
- By:
- Publication type:
- Article
Peripheral inflammation is associated with brain atrophy and cognitive decline linked to mild cognitive impairment and Alzheimer's disease.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67177-5
- By:
- Publication type:
- Article
Serum Bile Acids Improve Prediction of Alzheimer's Progression in a Sex‐Dependent Manner.
- Published in:
- Advanced Science, 2024, v. 11, n. 9, p. 1, doi. 10.1002/advs.202306576
- By:
- Publication type:
- Article
Comparison of Approaches for Equating Different Versions of the Mini-Mental State Examination Administered in 22 Studies.
- Published in:
- American Journal of Epidemiology, 2019, v. 188, n. 12, p. 2202, doi. 10.1093/aje/kwz228
- By:
- Publication type:
- Article
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 7, p. e197978, doi. 10.1001/jamanetworkopen.2019.7978
- By:
- Publication type:
- Article
Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression.
- Published in:
- Brain Communications, 2021, v. 3, n. 3, p. 1, doi. 10.1093/braincomms/fcab139
- By:
- Publication type:
- Article
Peripheral serum metabolomic profiles inform central cognitive impairment.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-70703-w
- By:
- Publication type:
- Article
ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01119-z
- By:
- Publication type:
- Article
Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's disease.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-04011-6
- By:
- Publication type:
- Article
Sex and APOE ε4 genotype modify the Alzheimer's disease serum metabolome.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14959-w
- By:
- Publication type:
- Article